Weight-loss drugs now linked to cancer protection in women, major new study reveals
PositiveU.S News

A groundbreaking study has revealed that GLP-1 medications, commonly used for weight loss, may also offer significant cancer protection for women, particularly against endometrial and ovarian cancers. This finding is crucial as it not only highlights the dual benefits of these drugs but also opens new avenues for cancer prevention strategies in obese adults. Oncologist Dr. Slomovitz emphasizes the importance of these results, suggesting that they could change how we approach treatment and prevention in this demographic.
— Curated by the World Pulse Now AI Editorial System